ANDA 213827

INNOGENIX

FDA Drug Application

Application #213827

Application Sponsors

ANDA 213827

INNOGENIX

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003

Application Products

001	TABLET;ORAL	2.5MG	0	METOLAZONE	METOLAZONE
002	TABLET;ORAL	5MG	0	METOLAZONE	METOLAZONE
003	TABLET;ORAL	10MG	0	METOLAZONE	METOLAZONE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2021-03-30

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB

CDER Filings

INNOGENIX

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213827
            [companyName] => INNOGENIX
            [docInserts] => ["",""]
            [products] => [{"drugName":"METOLAZONE","activeIngredients":"METOLAZONE","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"METOLAZONE","activeIngredients":"METOLAZONE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"METOLAZONE","activeIngredients":"METOLAZONE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/30\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-03-30
        )

)